The treatment and prevention of Alzheimer’s
(blood-brain barrier)
(blood-brain barrier)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
Alzheimer’s disease results from the deposit of something called Amyloid-ß protein peptides in the brain. These proteins collect over a period of time resulting in the formation of plaque. Some substances are thought to prevent the collection of Amyloid-ß peptides by binding to them. In the present study, researchers have explained two simple in vitro tests, the microplate method and the immunohistochemical method; these tests measure the efficacy of Amyloid-ß peptide collection blockers. Using these techniques, researchers evaluated the efficacy of various agents that are believed to slow the progression of Alzheimer’s disease. Researchers developed two novel techniques to examine the Amyloid-ß peptide binding capacity of substances such as PGG, epigalocatechin gallate, diclofenac, resveratrol , myo-inositol, rhamnose, emodin, and the extracts of garlic, spirulina, cinnamon, ginger, blueberries and turmeric. Continue to read: fyiliving.com
Gut bacteria enterotypes linked to diet
The type of food you eat may help to determine the type of bacterial population – or enterotypes – in your gut, according to a new study. Read more: nutraingredients.com